Health authorities in the United Arab Emirates may start encouraging the sale of generic drugs to drive down the cost prescription medications. A senior official at the Abu Dhabi Health Authority Dhabi (HAAD) has called for the introduction of cost-effective drugs across Abu Dhabi through a strategy that does not compromise patient safety.
Speaking to the local newspaper Gulf News at the first annual Middle East Generic Medicine Conference, Mohammad Abu Al Khair, section head of HAAD's Drugs and Medical Products
Regulation Department, said UAE pharmaceutical sales were amongst the highest in the world. The usage of pharmaceutical products in the UAE has grown at a rate of 21% per annum above the world average.
The HAAD is considering tackling the high prices by putting a ceiling on the payments from insurance companies to pharmacies. Insurers pay out 100% of a drug's value when they receive a bill from a pharmacy.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze